Skip to main content
Erschienen in: Supportive Care in Cancer 12/2023

01.12.2023 | Review

Quality of life in patients with malignant spinal cord compression: a systematic review

verfasst von: Milena Gojsevic, Saba Shariati, Adrian Wai Chan, Pierluigi Bonomo, Elwyn Zhang, Samantha K. F. Kennedy, Thenugaa Rajeswaran, Dirk Rades, Vassilios Vassiliou, Hany Soliman, Shing-Fung Lee, Henry C. Y. Wong, Agata Rembielak, Eva Oldenburger, Shereen Akkila, Lucas Azevedo, Edward Chow, On behalf of EORTC Quality of Life Group

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2023

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Malignant spinal cord compression (MSCC) is an oncological emergency that may result in a devastating combination of malignancy and disability. Existing quality of life (QoL) questionnaires commonly used in MSCC literature (EORTC QLQ-C30, BM-22, Brief Pain Inventory, and Spine Oncology Study Group Outcomes) may not capture all the commonly reported symptoms and lack specificity to MSCC. The primary objective of this systematic review is to determine unmet patient needs and underreported QoL issues and compile a comprehensive list of QoL issues. The secondary objective of this review is to compile all existing QoL tools and questionnaires and determine whether any QoL issues are not addressed in the existing tools currently used in the literature.

Methods

A literature search was conducted on Ovid MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials databases between 1946 and February 6, 2023, to compile all QoL issues and existing questionnaires used to assess QoL in patients with MSCC. All study designs were included given that they discussed QoL issues specific to patients with MSCC.

Results

The results of this systematic review identified the most frequently discussed QoL issues in the literature studying MSCC. This included direct symptoms of MSCC such as back pain, paralysis, limb weakness/numbness, and urinary/bowel incontinence. Indirect symptoms coming from radiotherapy treatment such as dysphagia, painful swallowing, mouth pain, dry mouth, diarrhea, fatigue, and nausea/vomiting were also noted. Other symptoms resulting from corticosteroid treatment included difficulty sleeping, blurring of vision, weight gain, and mood disturbance. Patients also experienced psychosocial issues such as anxiety, depression, emotional distress, low self-esteem, concerns about dependence on others, concerns about getting home, and fear about their prognosis and future.

Conclusion

This review highlights the QoL issues specific to patients with MSCC and QoL tools capturing these issues. Relevance of QoL issues identified in this systematic review must be prospectively validated by patients and healthcare professionals with experience in treating MSCC.
Literatur
5.
30.
Zurück zum Zitat Ampil FL, Apple S, Bell MC (1998) Spinal epidural compression complicating cancer of the cervix: Review of seven cases. Eur J Gynaecol Oncol 19:105–107PubMed Ampil FL, Apple S, Bell MC (1998) Spinal epidural compression complicating cancer of the cervix: Review of seven cases. Eur J Gynaecol Oncol 19:105–107PubMed
47.
Zurück zum Zitat Harrington KD (1988) Anterior decompression and stabilization of the spine as a treatment for vertebral collapse and spinal cord compression from metastatic malignancy. Clin Orthop Relat Res 233:177–197CrossRef Harrington KD (1988) Anterior decompression and stabilization of the spine as a treatment for vertebral collapse and spinal cord compression from metastatic malignancy. Clin Orthop Relat Res 233:177–197CrossRef
52.
Zurück zum Zitat Ibrahim A, Crockard A, Antonietti P et al (2008) Does spinal surgery improve the quality of life for those with extradural (spinal) osseous metastases? An international multicenter prospective observational study of 223 patients. J Neurosurg Spine 8:271–278 https://doi.org/10.3171/SPI/2008/8/3/271 Ibrahim A, Crockard A, Antonietti P et al (2008) Does spinal surgery improve the quality of life for those with extradural (spinal) osseous metastases? An international multicenter prospective observational study of 223 patients. J Neurosurg Spine 8:271–278 https://​doi.​org/​10.​3171/​SPI/​2008/​8/​3/​271
61.
63.
Zurück zum Zitat Nater A, Tetreault LA, Kopjar B et al (2018) Predictive factors of survival in a surgical series of metastatic epidural spinal cord compression and complete external validation of 8 multivariate models of survival in a prospective North American multicenter study. Cancer 124(17):3536–3550. https://doi.org/10.1002/cncr.31585CrossRefPubMed Nater A, Tetreault LA, Kopjar B et al (2018) Predictive factors of survival in a surgical series of metastatic epidural spinal cord compression and complete external validation of 8 multivariate models of survival in a prospective North American multicenter study. Cancer 124(17):3536–3550. https://​doi.​org/​10.​1002/​cncr.​31585CrossRefPubMed
149.
Zurück zum Zitat Birren JE (2007) Disability, functional status, and activities of daily living. Encyclopedia of gerontology 427–436. Essay, Academic Press Birren JE (2007) Disability, functional status, and activities of daily living. Encyclopedia of gerontology 427–436. Essay, Academic Press
158.
Zurück zum Zitat Cleeland CS, Ryan KM (1994) Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap 23(2):129–38PubMed Cleeland CS, Ryan KM (1994) Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap 23(2):129–38PubMed
159.
Metadaten
Titel
Quality of life in patients with malignant spinal cord compression: a systematic review
verfasst von
Milena Gojsevic
Saba Shariati
Adrian Wai Chan
Pierluigi Bonomo
Elwyn Zhang
Samantha K. F. Kennedy
Thenugaa Rajeswaran
Dirk Rades
Vassilios Vassiliou
Hany Soliman
Shing-Fung Lee
Henry C. Y. Wong
Agata Rembielak
Eva Oldenburger
Shereen Akkila
Lucas Azevedo
Edward Chow
On behalf of EORTC Quality of Life Group
Publikationsdatum
01.12.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 12/2023
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-023-08186-4

Weitere Artikel der Ausgabe 12/2023

Supportive Care in Cancer 12/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.